We are live on ! Find out more
YMRC

Yorktown Management & Research Company Portfolio holdings

AUM $163M
1-Year Est. Return 68.53%
This Fund
S&P 500
This Quarter Est. Return
+26.24%
1 Year Est. Return
+68.53%
3 Year Est. Return
+222.75%
5 Year Est. Return
+299.09%
10 Year Est. Return
+935.04%
AUM
$111M
AUM Growth
+$4.13M
Cap. Flow
-$15.2M
Cap. Flow %
-13.66%
Top 10 Hldgs %
13.99%
Holding
264
New
29
Increased
8
Reduced
60
Closed
45

Top Sells

Rank Stock Value
1
BLK icon
Blackrock
BLK
+$925K
2
CHH icon
Choice Hotels
CHH
+$876K
3
CPK icon
Chesapeake Utilities
CPK
+$691K
4
EQIX icon
Equinix
EQIX
+$677K
5
CTAS icon
Cintas
CTAS
+$649K

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Consumer Discretionary 16.75%
3 Healthcare 14.95%
4 Industrials 13.9%
5 Financials 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTGT icon
1
TechTarget
TTGT
$262M
$1.81M 1.63%
30,600
-1,400
-4% -$72.3K
RGEN icon
2
Repligen
RGEN
$9.2B
$1.75M 1.58%
9,150
GNRC icon
3
Generac Holdings
GNRC
$12.4B
$1.73M 1.55%
7,600
NOVT icon
4
Novanta
NOVT
$6.24B
$1.62M 1.46%
13,700
LPLA icon
5
LPL Financial
LPLA
$29.2B
$1.58M 1.43%
15,200
-500
-3% -$44.9K
WING icon
6
Wingstop
WING
$3.24B
$1.49M 1.34%
11,200
-600
-5% -$78.3K
LAD icon
7
Lithia Motors
LAD
$8.22B
$1.48M 1.33%
5,050
-600
-11% -$164K
MORN icon
8
Morningstar
MORN
$7.63B
$1.39M 1.25%
6,000
PLUG icon
9
Plug Power
PLUG
$2.94B
$1.36M 1.22%
+40,000
New +$906K
FN icon
10
Fabrinet
FN
$19.1B
$1.35M 1.21%
17,400
-800
-4% -$54.4K
CRSP icon
11
CRISPR Therapeutics
CRSP
$5.27B
$1.32M 1.19%
8,600
ETSY icon
12
Etsy
ETSY
$7.57B
$1.3M 1.17%
7,300
MLAB icon
13
Mesa Laboratories
MLAB
$567M
$1.2M 1.08%
4,200
NEO icon
14
NeoGenomics
NEO
$2.14B
$1.12M 1.01%
20,800
-1,200
-5% -$54.2K
MPWR icon
15
Monolithic Power Systems
MPWR
$68.3B
$1.1M 0.99%
3,000
TWST icon
16
Twist Bioscience
TWST
$7.72B
$1.03M 0.93%
7,300
AUDC icon
17
AudioCodes
AUDC
$254M
$1M 0.9%
36,400
-1,700
-4% -$49.9K
NVEE
18
DELISTED
NV5 Global
NVEE
$977K 0.88%
49,600
-2,400
-5% -$40.4K
FIVE icon
19
Five Below
FIVE
$13.3B
$892K 0.8%
5,100
NTLA icon
20
Intellia Therapeutics
NTLA
$1.7B
$816K 0.73%
15,000
-1,000
-6% -$36.3K
CCK icon
21
Crown Holdings
CCK
$13B
$802K 0.72%
8,000
EXPE icon
22
Expedia Group
EXPE
$37.4B
$794K 0.71%
6,000
POWI icon
23
Power Integrations
POWI
$3.46B
$794K 0.71%
9,700
-900
-8% -$61.1K
MLI icon
24
Mueller Industries
MLI
$15.3B
$782K 0.7%
89,064
-4,800
-5% -$38.4K
EVTC icon
25
Evertec
EVTC
$1.76B
$743K 0.67%
18,900
-800
-4% -$29.7K

Similar funds

Yorktown Management & Research Company's Q4 2020 Portfolio in Review

As of Q4 2020, Yorktown Management & Research Company held 264 positions worth $111M, up 3.9% from $107M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Yorktown Management & Research Company withdrew a net $15.2M in Q4 2020, closing 45 positions and reducing 60 holdings. Its most notable exit was Choice Hotels, an estimated $876K position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Yorktown Management & Research Company opened a new position in Plug Power worth $1.36M.

  • Yorktown Management & Research Company's largest Q4 2020 buy was Plug Power: 40,000 shares worth $1.36M.
  • Yorktown Management & Research Company added most to Deere & Co in Q4 2020, an estimated $59.6K increase.
  • Yorktown Management & Research Company's biggest Q4 2020 reduction was Blackrock, cutting an estimated $925K.
  • Yorktown Management & Research Company fully exited Choice Hotels in Q4 2020, selling an estimated $876K.
  • Yorktown Management & Research Company's ten largest holdings make up 14% of its $111M portfolio in Q4 2020.
  • Yorktown Management & Research Company opened 29 new positions and closed 45 in Q4 2020.
  • Yorktown Management & Research Company's portfolio value rose 3.9% quarter-over-quarter to $111M.

Based on Yorktown Management & Research Company's 13F filing for Q4 2020, filed 11 Feb 2021.